InvestorsHub Logo
Followers 134
Posts 3756
Boards Moderated 0
Alias Born 01/28/2006

Re: Jhawker post# 330759

Saturday, 10/31/2020 2:41:22 PM

Saturday, October 31, 2020 2:41:22 PM

Post# of 403584
IPIX has stated it may study Brilacidin against a variety of pulmonary diseases. Possible targets are asthma, COPD, chronic bronchitis,bronchiectasis, cystic fibrosis, pulmonary fibrosis and others.

GLTA Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News